Studies with murine LPC-1 plasmacytoma using [6-14C]arginine.
[16-14C]Arginine ([6-14C]Arg) was used as an in vivo pulse label to study BALB/c murine LPC-1 plasmacytoma synthesis and secretion of its tumour-associated M component (IgG2a, kappa). With this isotope, an eight- to ten-fold enhancement in the labelling of the gamma globulin region and ten-fold reduction in the albumin labelling were observed. Production and secretion of the M component was detected (within 30 min) after cell transfer. Only mice which received tumour cells showed significant labelling in the gamma globulin region 24 hr after isotope injection. The labelling behaviour of the tumour M component correlated with the administered cell dose. The peak heights of radioactivity in the gamma region increased with increments in cell number. When the percentage radioactivity diverted into M component was plotted as a function of cell dose, a linear relationship was noted. This study demonstrates the feasibility of using [6-14C]Arg as a tool to follow the newly synthesized tumour-associated protein, and provides a means of estimating tumour cell number.
D000818:Animals; D001120:Arginine; D001797:Blood Protein Electrophoresis; D002250:Carbon Radioisotopes; D005260:Female; D051379:Mice; D009194:Myeloma Proteins / Q000097:blood*; D009368:Neoplasm Transplantation; D010954:Plasmacytoma / Q000097:blood*; D005719:gamma-Globulins / Q000032:analysis
D002250:Carbon Radioisotopes; D009194:Myeloma Proteins; D005719:gamma-Globulins; D001120:Arginine